Reference : 10 years of denosumab treatment in postmenopausal women with osteoporosis: results fr...
Scientific journals : Article
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/213751
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
English
Bone, H.G. []
Wagman, R.B. []
Brandi, M.L. []
Brown, J.P. []
Chapurlat, R. []
Cummings, S.R. []
Czerwiski, E. []
Fahrleitner-Pammer, A. []
Kendler, D.L. []
Lippuner, K. []
Reginster, Jean-Yves mailto [Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Roux, C. []
Malouf, J. []
Bradley, N.M. []
Daizadeh, N.S. []
Wang, A. []
Dakin, P. []
Pannacciulli, N. []
Dempster, D.W. []
Papapopoulos, S. []
Jul-2017
Lancet Diabetes and Endocrinology
Elsevier
5
513-523
Yes (verified by ORBi)
International
2213-8587
2213-8595
http://hdl.handle.net/2268/213751
10.1016/S2213-8587(17)30138-9

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
10 years of denosumab treatment in postmenopausal wome with osteoporosis. Results from the phase 3 randomised FREEDOM trial open-label extension.pdfPublisher postprint1.04 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.